- Diseases
- Acoustic Neuroma (14)
- Adrenal Gland Tumor (24)
- Anal Cancer (66)
- Anemia (2)
- Appendix Cancer (16)
- Bile Duct Cancer (26)
- Bladder Cancer (68)
- Brain Metastases (28)
- Brain Tumor (230)
- Breast Cancer (718)
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (2)
- Cancer of Unknown Primary (4)
- Carcinoid Tumor (8)
- Cervical Cancer (154)
- Colon Cancer (164)
- Colorectal Cancer (110)
- Endocrine Tumor (4)
- Esophageal Cancer (42)
- Eye Cancer (36)
- Fallopian Tube Cancer (6)
- Germ Cell Tumor (4)
- Gestational Trophoblastic Disease (2)
- Head and Neck Cancer (6)
- Kidney Cancer (124)
- Leukemia (344)
- Liver Cancer (50)
- Lung Cancer (288)
- Lymphoma (284)
- Mesothelioma (14)
- Metastasis (30)
- Multiple Myeloma (98)
- Myelodysplastic Syndrome (60)
- Myeloproliferative Neoplasm (4)
- Neuroendocrine Tumors (16)
- Oral Cancer (100)
- Ovarian Cancer (170)
- Pancreatic Cancer (164)
- Parathyroid Disease (2)
- Penile Cancer (14)
- Pituitary Tumor (6)
- Prostate Cancer (144)
- Rectal Cancer (58)
- Renal Medullary Carcinoma (6)
- Salivary Gland Cancer (14)
- Sarcoma (236)
- Skin Cancer (296)
- Skull Base Tumors (56)
- Spinal Tumor (12)
- Stomach Cancer (60)
- Testicular Cancer (28)
- Throat Cancer (90)
- Thymoma (6)
- Thyroid Cancer (98)
- Tonsil Cancer (30)
- Uterine Cancer (78)
- Vaginal Cancer (14)
- Vulvar Cancer (18)
- Cancer Topic
- Adolescent and Young Adult Cancer Issues (20)
- Advance Care Planning (10)
- Biostatistics (2)
- Blood Donation (18)
- Bone Health (8)
- COVID-19 (362)
- Cancer Recurrence (120)
- Childhood Cancer Issues (120)
- Clinical Trials (628)
- Complementary Integrative Medicine (24)
- Cytogenetics (2)
- DNA Methylation (4)
- Diagnosis (230)
- Epigenetics (6)
- Fertility (64)
- Follow-up Guidelines (2)
- Health Disparities (14)
- Hereditary Cancer Syndromes (124)
- Immunology (18)
- Li-Fraumeni Syndrome (8)
- Mental Health (118)
- Molecular Diagnostics (8)
- Pain Management (62)
- Palliative Care (8)
- Pathology (10)
- Physical Therapy (18)
- Pregnancy (18)
- Prevention (898)
- Research (392)
- Second Opinion (74)
- Sexuality (16)
- Side Effects (604)
- Sleep Disorders (10)
- Stem Cell Transplantation Cellular Therapy (216)
- Support (404)
- Survivorship (322)
- Symptoms (184)
- Treatment (1776)
Pediatric leukemia survivor gives back to MD Anderson at Southwest Airlines LUV Classic
2 minute read | Published October 19, 2017
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on October 19, 2017
Ethan Tepera was only 13 years old when he was diagnosed with chronic myeloid leukemia (CML) in October 2011. He’d been pale and feeling nauseated for several weeks. Then, the migraines began.
“Initially, the pain was manageable,” Ethan says. “But eventually, it got so bad I couldn’t sleep or tolerate any light whatsoever.”
Ethan’s mother took him to a pediatrician near their home in Dallas. That doctor discovered Ethan was anemic. Additional blood tests revealed he also had leukemia.
“I was actually pretty relieved to find out,” Ethan says. “Because once the doctors knew what was wrong, we finally understood why I’d been having all these strange symptoms.”
The move to MD Anderson
Initially, Ethan sought treatment at a Dallas hospital, but after three different treatment plans failed to keep the leukemia from progressing, it became clear his family needed to try something else.
Then, his parents heard about MD Anderson Children’s Cancer Hospital from another patient’s family. Ethan discovered he could get a haplo-identical stem cell transplant here and participate in a clinical trial involving T-cell therapy. At the time, MD Anderson was one of the only hospitals where the clinical trial was available.
“Once we visited MD Anderson for the first time, the expertise we saw in the doctors was enough to convince us that it was the right choice,” Ethan says. “And from a kid’s point of view, it felt more like a temporary home than a hospital.”
No evidence of disease after leukemia treatment
At MD Anderson Children’s Cancer Hospital, Ethan received high-dose chemotherapy and 12 rounds of proton therapy under Demetrios Petropoulos, M.D., in preparation for his stem cell transplant.
Ethan has shown no evidence of disease since December 2013. Today, he is a college freshman studying zoology. The 19-year-old pays forward the care he received at MD Anderson both by aiming to become a pediatric oncologist himself some day and by participating in the recent Southwest Airlines® 32nd Annual LUV Classic. The golf tournament was held on Friday, Oct. 6, 2017, and benefited several charities, including the Children's Cancer Hospital.
“There are so many families who spend their life savings on cancer medication and treatment, in the hopes that treatment will allow them to live,” Ethan says. “Fundraising events like the Southwest LUV Classic are why MD Anderson is able to give financial aid scholarships to patients and families in need, saving many lives.”
Request an appointment at MD Anderson online or by calling 1-844-478-0752.
Related Cancerwise Stories

MD Anderson felt more like a temporary home than a hospital.
Ethan Tepera
Survivor